Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In re Impax Laboratories, Inc. Shareholder Derivative Litigation
Case Number:
3:14-cv-04266
Court:
Nature of Suit:
Multi Party Litigation:
Derivative Litigation
Judge:
Firms
Companies
Sectors & Industries:
-
September 04, 2015
Impax Board Dodges Suit Over Bugs In Its Drugs, For Now
A California federal judge on Thursday dismissed a lawsuit accusing directors of Impax Laboratories Inc. of doing nothing to correct warnings about its drugmaking quality safeguards and fibbing about its efforts, holding that the plaintiffs must establish they made demands in the boardroom before turning to the courtroom.
-
April 27, 2015
Impax Board Slams Investor Suit Over Compliance Gaffes
Impax Laboratories Inc. asked a California federal judge Friday to toss a shareholder derivative suit accusing its board of directors of allowing recurring regulatory compliance failures, saying the complaint falls short of showing a lack of board oversight or a disregard of any alleged "red flags" raised over its drug production.